Cargando…
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer
2-Methoxyestradiol (2-ME(2)) possesses anti-tumorigenic activities in multiple tumor models with acceptable tolerability profile in humans. Incomplete understanding of the mechanism has hindered its development as an anti-tumorigenic compound. We have identified for the first-time macrophage stimula...
Autores principales: | Batth, Izhar Singh, Huang, Shih-Bo, Villarreal, Michelle, Gong, Jingjing, Chakravarthy, Divya, Keppler, Brian, Jayamohan, Sridharan, Osmulski, Pawel, Xie, Jianping, Rivas, Paul, Bedolla, Roble, Liss, Michael A., Yeh, I-Tien, Reddick, Robert, Miyamoto, Hiroshi, Ghosh, Rita, Kumar, Addanki P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918140/ https://www.ncbi.nlm.nih.gov/pubmed/33673346 http://dx.doi.org/10.3390/ijms22041852 |
Ejemplares similares
-
Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
por: Batth, Izhar, et al.
Publicado: (2016) -
2-methoxyestradiol Prevents LNCaP Tumor Development in Nude Mice: Potential Role of G(2)/M Regulatory Proteins
por: Horny, Cara, et al.
Publicado: (2009) -
Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence
por: Bedolla, Roble G., et al.
Publicado: (2012) -
Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model
por: Patel, Darpan I., et al.
Publicado: (2019) -
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions
por: Yun, Huiyoung, et al.
Publicado: (2018)